Patents by Inventor Ruprecht-Karls-Universitaet Heidelberg

Ruprecht-Karls-Universitaet Heidelberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Parvovirus Cancer Therapy and Combination with Chemotherapy
    Publication number: 20140234261
    Abstract: Described is a pharmaceutical composition containing (a) a parvovirus and (b) a chemotherapeutic agent, preferably as separate entities. The parvovirus might be based on parvovirus H1, LuIII, Mouse minute virus (MMV), Mouse parvovirus (MPV), Rat minute virus (RMV), Rat parvovirus (RPV), Rat virus (RV), vectors based on the foregoing viral species, and/or cells capable of actively producing the foregoing viral species. The pharmaceutical composition is beneficial for the treatment of a tumor. Tumors for which a parvovirus or the adjunction of the invention has particular utility include glioma, medulloblastoma, meningioma and pancreatic cancer. Preferred chemotherapeutic agents are gemcitabine and Temozolodine.
    Type: Application
    Filed: March 7, 2013
    Publication date: August 21, 2014
    Applicants: Ruprecht-Karls-Universitaet Heidelberg, Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts
    Inventors: Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts, Ruprecht-Karls-Universitaet Heidelberg